Mostrando 2 resultados de: 2
Filtros aplicados
Subtipo de publicación
Article(2)
Área temáticas
Medicina y salud(2)
Medicina forense; incidencia de enfermedades(1)
Microorganismos, hongos y algas(1)
Origen
scopus(2)
Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study
ArticleAbstract: Background: The SARS-CoV-2 delta (B.1.617.2) variant was first detected in England in March, 2021. IPalabras claves:Autores:Aanensen D.M., Abudahab K., Adams H., Afifi S., Aliabadi S., Ash A., Batra R., Beckett A.H., Beer R., Bernardo M. Gutierrez, Berry L., Betancor G., Bird P.W., Blakey V., Bonsall D., Boswell T., Bresner C., Campbell S., Carlile M., Charalampous T., Charlett A., Clark G., Cogger B.J., Coll F., Connor T.R., Cortes N., Curran T., Dabrera G., De Angelis D., Debebe J., Edgeworth J., Fairley D.J., Fallon K., Fleming V.M., Fraser C., Fuller W., Gallagher E., Golubchik T., Guest M., Gulliver H., Harris R.J., Hassan-Ibrahim M.O., Helmer T., Holmes C., Holmes N., Hope R., Howson-Wells H.C., John M., Jones C., Joseph A., Khakh M., Kidd S., Kitchen C., Koshy C., Lister M.M., Loose M.W., Lopez-Bernal J., Lynch J., Maksimovic J., Malone C.S., Marchbank A., McCluggage K., McKenna J.P., Menegazzo M., Merrick I., Moore C., Moore N., Morgan S., Mori M., Munn R., Nebbia G., Nyberg T., Patel A., Presanis A.M., Price A., Raviprakash V., Reynolds N., Robson S.C., Sang F., Seaman S.R., Sheriff N., Signell A.W., Sinnathamby M.A., Smith W., Snell L.B., Southgate J., Spellman K., Tang J., Taylor B.E.W., Thelwall S., Twohig K.A., Underwood A.P., Wantoch M., Warne B., Williams L.A., Willingham I., Wise E.L., Workman T., Wright V., Yeats C.A., Zaidi A.Fuentes:scopusRecurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7
ArticleAbstract: We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike ΔH69/V70 in multiple inPalabras claves:Alpha variant, antibody escape, B.1.1.7, covid-19, deletion, infectivity, neutralizing antibodies, RESISTANCE, SARS-COV-2, spike mutationAutores:Aanensen D.M., Aggarwal D., Alderton A., Amato R., Andersson M.I., Ariani C.V., Awan A.R., Barrett J., Bashton M., Bassett A.R., Bernardo M. Gutierrez, Bonsall D., Bucca G., Bull M., Chand M., Chapman M.H.S., Chauhan A.J., Collier D.A., Connor T.R., Constantinidou C., Corden S., Cottrell S., Curran M.D., Darby A.C., Datir R.P., de Silva T.I., Dewar R., Elliott S., Fairley D.J., Ferreira I.A.T.M., Gallo G., Glaysher S., Golubchik T., Goncalves S., Hamilton W.L., Harrison E.M., Harvey W.T., Hassan-Ibrahim M.O., Hiscox J.A., Holden M.T.G., Jackson D.K., Jahun A.S., Jesudason N.G., Johnston I., Kemp S.A., Kwiatkowski D.P., Langford C.F., Lawniczak M., Li K.K., Livett R., Loman N.J., Loose M.W., Loveson K.F., Lowe H., Ludden C., Lytras S., Marelli S., Martincorena I., Martinez Nunez R.T., McCann C.M., McHugh M.P., McKenna J.P., McMurray C., Meng B., Mlcochova P., Mohamed A., Moore C., Moses S., Nelson A., Nicholls S.M., Osman H., O’Grady J., Pacchiarini N., Page A.J., Pandey S., Papa G., Parker M.D., Parmar S., Paterson S., Prieto J.A., Pybus O.G., Rambaut A., Robson S.C., Saeed K., Shah R.N., Shepherd J.G., Sillitoe J., Smith C.P., Smith D.L., Snell L.B., Taha Y., Templeton K.E., Thakur N., Thomson E.C., Torok M.E., Underwood A.P., Unnikrishnan M., Volz E.M., Wang D., Watkins J., Young G.R.Fuentes:scopus